NVST Envista Holdings Corporation

매출 +12% 성장. 다만 애널리스트 전망 하향 우세. 11/4 실적 발표 예정.

종가$23.19
시가총액$37억
업종헬스케어
다음 실적 발표2026-11-04
PER38.7배
매출 성장(최근 4분기)+12%
영업이익률9.6%
애널리스트 순상향률-40%
목표가 상승여력+24%
공매도 거래 비중60%
유명 투자자 보유2곳
1년 수익률+15%

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic tre

2026-10-21 기준 · 출처: SEC EDGAR, FINRA, yfinance · 정보 제공용이며 투자 권유가 아닙니다

같은 업종 종목